CV Sciences, Inc. (OTCMKTS:CVSI) Stock Short Interest Jumps 123.1%

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a large growth in short interest in September. As of September 30th, there was short interest totaling 14,190 shares, a growth of 123.1% from the September 15th total of 6,360 shares. Based on an average daily volume of 1,839,462 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company’s stock are short sold.

CV Sciences Stock Performance

CV Sciences stock traded up $0.00 during mid-day trading on Wednesday, reaching $0.01. 17,125 shares of the company’s stock were exchanged, compared to its average volume of 819,981. The business’s fifty day simple moving average is $0.02 and its 200 day simple moving average is $0.02. CV Sciences has a one year low of $0.01 and a one year high of $0.10.

CV Sciences Company Profile

CV Sciences, Inc is a life sciences company focused on hemp-derived cannabidiol (CBD) consumer products. The company develops, manufactures, and markets products under its PlusCBD brand, including CBD oils, softgels, gummies, capsules, topicals, and products formulated for pets.

PlusCBD products are positioned for use in areas such as general wellness, relaxation, sleep, and recovery. CV Sciences distributes its products through e-commerce channels and a network of retail outlets, primarily in the United States, subject to applicable regulations governing hemp-derived products and dietary supplements.

Founded in 2012, CV Sciences has historically focused on cannabinoid-based consumer health products and related research.